BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31498409)

  • 1. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.
    Samet JM; Chiu WA; Cogliano V; Jinot J; Kriebel D; Lunn RM; Beland FA; Bero L; Browne P; Fritschi L; Kanno J; Lachenmeier DW; Lan Q; Lasfargues G; Le Curieux F; Peters S; Shubat P; Sone H; White MC; Williamson J; Yakubovskaya M; Siemiatycki J; White PA; Guyton KZ; Schubauer-Berigan MK; Hall AL; Grosse Y; Bouvard V; Benbrahim-Tallaa L; El Ghissassi F; Lauby-Secretan B; Armstrong B; Saracci R; Zavadil J; Straif K; Wild CP
    J Natl Cancer Inst; 2020 Jan; 112(1):30-37. PubMed ID: 31498409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble.
    Baan RA; Straif K
    ALTEX; 2022; 39(3):443–450. PubMed ID: 34164695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program.
    Goodman JE; Mayfield DB; Becker RA; Hartigan SB; Erraguntla NK
    Regul Toxicol Pharmacol; 2020 Jun; 113():104639. PubMed ID: 32147291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IARC monographs: 40 years of evaluating carcinogenic hazards to humans.
    Pearce N; Blair A; Vineis P; Ahrens W; Andersen A; Anto JM; Armstrong BK; Baccarelli AA; Beland FA; Berrington A; Bertazzi PA; Birnbaum LS; Brownson RC; Bucher JR; Cantor KP; Cardis E; Cherrie JW; Christiani DC; Cocco P; Coggon D; Comba P; Demers PA; Dement JM; Douwes J; Eisen EA; Engel LS; Fenske RA; Fleming LE; Fletcher T; Fontham E; Forastiere F; Frentzel-Beyme R; Fritschi L; Gerin M; Goldberg M; Grandjean P; Grimsrud TK; Gustavsson P; Haines A; Hartge P; Hansen J; Hauptmann M; Heederik D; Hemminki K; Hemon D; Hertz-Picciotto I; Hoppin JA; Huff J; Jarvholm B; Kang D; Karagas MR; Kjaerheim K; Kjuus H; Kogevinas M; Kriebel D; Kristensen P; Kromhout H; Laden F; Lebailly P; LeMasters G; Lubin JH; Lynch CF; Lynge E; 't Mannetje A; McMichael AJ; McLaughlin JR; Marrett L; Martuzzi M; Merchant JA; Merler E; Merletti F; Miller A; Mirer FE; Monson R; Nordby KC; Olshan AF; Parent ME; Perera FP; Perry MJ; Pesatori AC; Pirastu R; Porta M; Pukkala E; Rice C; Richardson DB; Ritter L; Ritz B; Ronckers CM; Rushton L; Rusiecki JA; Rusyn I; Samet JM; Sandler DP; de Sanjose S; Schernhammer E; Costantini AS; Seixas N; Shy C; Siemiatycki J; Silverman DT; Simonato L; Smith AH; Smith MT; Spinelli JJ; Spitz MR; Stallones L; Stayner LT; Steenland K; Stenzel M; Stewart BW; Stewart PA; Symanski E; Terracini B; Tolbert PE; Vainio H; Vena J; Vermeulen R; Victora CG; Ward EM; Weinberg CR; Weisenburger D; Wesseling C; Weiderpass E; Zahm SH
    Environ Health Perspect; 2015 Jun; 123(6):507-14. PubMed ID: 25712798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of carcinogenicity bioassays in the IARC monographs.
    Cogliano VJ
    Ann N Y Acad Sci; 2006 Sep; 1076():592-600. PubMed ID: 17119235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention, ethics and science: lessons from Lorenzo Tomatis.
    Zapponi GA; Marcello I; Carere A
    Ann Ist Super Sanita; 2008; 44(1):8-12. PubMed ID: 18469370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
    Huff J
    Int J Occup Environ Health; 2002; 8(3):249-70. PubMed ID: 12358081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten Years of Using Key Characteristics of Human Carcinogens to Organize and Evaluate Mechanistic Evidence in IARC Monographs on the Identification of Carcinogenic Hazards to Humans: Patterns and Associations.
    Rusyn I; Wright FA
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned.
    Turner MC; Cogliano V; Guyton K; Madia F; Straif K; Ward EM; Schubauer-Berigan MK
    Environ Health Perspect; 2023 Oct; 131(10):105001. PubMed ID: 37902675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: IARC Monographs Program and public health under siege by corporate interests.
    Infante PF; Melnick R; Vainio H; Huff J
    Am J Ind Med; 2018 Apr; 61(4):277-281. PubMed ID: 29397007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the International Agency for Research on Cancer's consideration of mechanistic evidence.
    Goodman J; Lynch H
    Toxicol Appl Pharmacol; 2017 Mar; 319():39-46. PubMed ID: 28162991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From hazard identification to weighing the benefits and drawbacks of prevention.
    Vainio H; Weiderpass E
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):28-33. PubMed ID: 16005922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Man-made mineral (vitreous) fibres: evaluations of cancer hazards by the IARC Monographs Programme.
    Baan RA; Grosse Y
    Mutat Res; 2004 Sep; 553(1-2):43-58. PubMed ID: 15288532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years of using key characteristics of human carcinogens to organize and evaluate mechanistic evidence in IARC Monographs on the identification of carcinogenic hazards to humans: Patterns and associations.
    Rusyn I; Wright FA
    Toxicol Sci; 2024 Feb; 198(1):141-154. PubMed ID: 38141214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritizing Chemicals for Risk Assessment Using Chemoinformatics: Examples from the IARC Monographs on Pesticides.
    Guha N; Guyton KZ; Loomis D; Barupal DK
    Environ Health Perspect; 2016 Dec; 124(12):1823-1829. PubMed ID: 27164621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining.
    Barupal DK; Schubauer-Berigan MK; Korenjak M; Zavadil J; Guyton KZ
    Environ Int; 2021 Nov; 156():106624. PubMed ID: 33984576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key characteristics of 86 agents known to cause cancer in humans.
    Krewski D; Bird M; Al-Zoughool M; Birkett N; Billard M; Milton B; Rice JM; Grosse Y; Cogliano VJ; Hill MA; Baan RA; Little J; Zielinski JM
    J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):244-263. PubMed ID: 31637961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IARC monographs: critics and controversy.
    Samet JM
    Carcinogenesis; 2015 Jul; 36(7):707-9. PubMed ID: 25943987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IARC program on the evaluation of the carcinogenic risk of chemicals to man.
    Tomatis L
    Ann N Y Acad Sci; 1976; 271():396-409. PubMed ID: 1069530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol.
    Cogliano VJ; Grosse Y; Baan RA; Straif K; Secretan MB; El Ghissassi F;
    Environ Health Perspect; 2005 Sep; 113(9):1205-8. PubMed ID: 16140628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.